Thomas G. Auchincloss, Director at CONCERT PHARMACEUTICALS, INC. (CNCE), bought 1,000 shares at $11.93 ($12K) on 2018-11-14, disclosed to the SEC on 2018-11-15.
Open-market purchase of $12k CNCE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CNCE | BUY | 2020-02-04 | $11K | — | Filing → |
| CNCE | BUY | 2018-11-19 | $12K | — | Filing → |
| CNCE | BUY | 2016-05-16 | $20K | — | Filing → |